Results 211 to 220 of about 205,182 (367)

Cell Cycle Activation of Peripheral Blood Stem and Progenitor Cells Expanded Ex Vivo with SCF, FLT‐3 Ligand, TPO, and IL‐3 Results in Accelerated Granulocyte Recovery in a Baboon Model of Autologous Transplantation but G ₀ /G ₁ and S/G ₂ /M Graft Cell Content Does Not Correlate with Tranplantability [PDF]

, 2001
M. Drouet, Françis Hérodin, Françoise Norol, Frédéric Mourcin, Jean-François Mayol   +4 more
openalex   +1 more source

Robust CAR T‐cell expansion and superior outcomes in DLBCL patients in complete response at infusion

British Journal of Haematology, EarlyView.
In this study, CAR T‐cell expansion and persistence were found to be comparable between CR and non‐CR groups, regardless of the co‐stimulatory domain (CD28 or 4‐1BB) or product used. Furthermore, peripheral blood kinetics—including absolute counts and proportions of total, CD4+ and CD8+ CAR T cells—showed no significant differences between the two ...
Ryo Hanajiri, Hiroya Wakabayashi, Kohei Ishigiwa, Fumiya Ohara, Shiho Hirano, Hirofumi Yokota, Shihomi Kuwano, Katsuya Furukawa, Kazuyuki Shimada, Takahiko Sato, Seitaro Terakura, Hitoshi Kiyoi   +11 more
wiley   +1 more source

Comparison of tandem and single autologous stem cell transplantation in multiple myeloma: a retrospective propensity score-matching study. [PDF]

Blood Sci
Wu SQ, Li XF, Qiu ZJ, Zhu ZJ, Chen XL, Chen P, Yuan XH, Zhan R, Li NN.   +8 more
europepmc   +1 more source

Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignancies

, 2000
Sophie Park, Pauline Brice, ME Noguerra, D. Simon, Philippe Rousselot, Y Kerneis, Pierre Morel, J-P Marolleau, C Gisselbrecht   +8 more
openalex   +1 more source

Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation [PDF]

, 2001
David Porter, Selina M. Luger, Kathleen M. Duffy, Edward A. Stadtmauer, Ginna G. Laport, Stephen J. Schuster, Gregory Orloff, Donald E. Tsai, Kevin McDaid, Kathakali Addya, Debra G. B. Leonard, Joseph H. Antin   +11 more
openalex   +1 more source

Temporal patterns in US population‐based patient survival among adults treated with chemotherapy and/or immunotherapy for multiple myeloma, 2000–2020

British Journal of Haematology, EarlyView.
Summary Few population‐based studies have rigorously evaluated overall survival (OS) differences among adults treated with chemotherapy and/or immunotherapy (chemo/immunotherapy) for multiple myeloma (MM) during the past two decades when the therapeutic landscape substantially evolved.
Graça M. Dores, Jacqueline B. Vo, Sara J. Schonfeld, Jaimie Z. Shing, Kekoa Taparra, Lindsay M. Morton, Rochelle E. Curtis, Martha S. Linet   +7 more
wiley   +1 more source

To consolidate or not to consolidate: the role of autologous stem cell transplantation in MCL. [PDF]

Hematology Am Soc Hematol Educ Program
Silkenstedt E, Dreyling M.
europepmc   +1 more source

High-dose chemotherapy with hematopoietic stem cell transplantation for patients with advanced multiple myeloma [PDF]

, 2000
Bamberg, M., Budach, W., Einsele, H., Emmerich, B., Straka, C.   +4 more
core   +1 more source

Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20‐year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)

British Journal of Haematology, EarlyView.
We report the UK experience of autologous haematopoietic stem cell transplantation (AHSCT) for multiple sclerosis (MS) in 364 patients. In our observational study, transplant‐related mortality was 1.4%, Epstein–Barr virus reactivation occurred in 75.9%, while disability progression‐free survival was 83.5% at 2 years post‐AHSCT and 62.4% at 5 years.
Majid Kazmi, Paolo A. Muraro, Varun Mehra, Ian Gabriel, Eleonora De Matteis, Gavin Brittain, Alice Mariottini, Richard Nicholas, Eli Silber, Julia Lee, Rachel Pearce, Ruth Paul, Maria Pia Sormani, Alessio Signori, Victoria Potter, Eduardo Olavarria, Ram Malladi, Basil Sharrack, John A. Snowden   +18 more
wiley   +1 more source

Clinical benefit loss in myeloma patients declining autologous stem cell transplantation: a real-world study. [PDF]

Discov Oncol
Wang Y, Xiong Y, Gu S, Wang W, Yang Y, Liu P.   +5 more
europepmc   +1 more source